Christina Marie Wyatt, MD

Associate Professor of Medicine
Member of the Duke Clinical Research Institute
Email address christina.wyatt@duke.edu

Education and Training

  • Chief Resident, Medicine, Icahn School of Medicine at Mount Sinai, 2004 - 2005
  • Nephrology Fellowship, Icahn School of Medicine at Mount Sinai, 2002 - 2004
  • Internal Medicine Residency, Medicine, Icahn School of Medicine at Mount Sinai, 1999 - 2002
  • M.D., Duke University School of Medicine, 1999

Publications

Ronco, P., B. H. Rovin, P. T. Coates, O. Devuyst, T. B. Drueke, J. Floege, A. B. Fogo, et al. “Looking back and moving forward (Accepted).” Kidney International 99, no. 4 (April 1, 2021): 787–90. https://doi.org/10.1016/j.kint.2021.02.001.

Full Text

Nickolas, Thomas L., Jonathan Barasch, Kenneth K. Mugwanya, Andrea D. Branch, Renee Heffron, Valentine Wanga, Nelly R. Mugo, et al. “Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis.” Aids, March 11, 2021. https://doi.org/10.1097/QAD.0000000000002865.

PMID
33710023
Full Text

Mounzer, Karam, Laurence Brunet, Christina M. Wyatt, Jennifer S. Fusco, Vani Vannappagari, Allan R. Tenorio, Mark S. Shaefer, Leigh Ragone, Ricky K. Hsu, and Gregory P. Fusco. “To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.” Aids, March 10, 2021. https://doi.org/10.1097/QAD.0000000000002871.

PMID
33710017
Full Text

Hughes, Kelly, Jerry Chang, Hannah Stadtler, Christina Wyatt, Mary Klotman, and Maria Blasi. “HIV-1 infection of the kidney: mechanisms and implications.” Aids 35, no. 3 (March 1, 2021): 359–67. https://doi.org/10.1097/QAD.0000000000002753.

PMID
33229896
Full Text

Ronco, Pierre, Brad Rovin, Masaomi Nangaku, Christina Wyatt, Vivek Jha, and Vivek Associate Editors, for the Entire Editorial Team. “Milestones in nephrology and welcoming the future: the 61st anniversary of the International Society of Nephrology.” Kidney Int 99, no. 1 (January 2021): 2–4. https://doi.org/10.1016/j.kint.2020.10.020.

PMID
33390227
Full Text

Edmonston, Daniel L., Matthew T. Roe, Geoffrey Block, Paul T. Conway, Laura M. Dember, Peter M. DiBattiste, Tom Greene, et al. “Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.” Am J Kidney Dis 76, no. 6 (December 2020): 842–50. https://doi.org/10.1053/j.ajkd.2020.05.026.

PMID
32768631
Full Text

Hung, Anna, Matthew Sinclair, Marion Hemmersbach-Miller, Daniel Edmonston, and Christina Wyatt. “Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide.” J Manag Care Spec Pharm 26, no. 12 (December 2020): 1582–88. https://doi.org/10.18553/jmcp.2020.26.12.1582.

PMID
33251997
Full Text

Hsu, R., L. Brunet, J. Fusco, A. Beyer, G. Prajapati, C. Wyatt, M. Wohlfeiler, and G. Fusco. “Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.” Hiv Med, November 28, 2020. https://doi.org/10.1111/hiv.13019.

PMID
33247876
Full Text

Brunet, Laurence, Christina Wyatt, Ricky Hsu, Karam Mounzer, Jennifer Fusco, and Gregory Fusco. “Assessing bias introduced in estimated glomerular filtration rate by the inhibition of creatinine tubular secretion from common antiretrovirals.” Antivir Ther, November 19, 2020. https://doi.org/10.3851/IMP3373.

PMID
33211670
Full Text

Pages